Lv1
10 积分 2024-01-08 加入
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
1年前
已完结
Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study
1年前
已完结
BCMA-TargetedT-Cell-EngagerTherapyforAutoimmuneDisease
1年前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
1年前
已完结
Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date
1年前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1年前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial
1年前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
1年前
已完结
少肌性肥胖的研究进展
1年前
已完结
皖公网安备34019202002308
